Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fundação Pio Xii shows a singular prosecution focus within the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently active, which is assigned to 1 distinct art unit. This suggests a very specialized technical scope for the entity's current patenting activities.
The prosecution is managed by 1 distinct examiner, HANEY, AMANDA MARIE, who is also the busiest examiner with 1 busiest examiner pending action. With only one examiner and one art unit involved, the entity's current interaction with the patent office is highly concentrated. This singular point of contact defines the current prosecution landscape for the organization.
Practitioners should focus on the specific procedural and technical preferences of the assigned examiner. Because the entire pending portfolio is subject to a single individual's review, the strategy must be precisely calibrated to that examiner's standards. This high level of concentration simplifies docket management but increases the importance of each filing.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16967500 | METHOD AND KIT FOR THE CLASSIFICATION OF THYROID NODULES | HANEY, AMANDA MARIE | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16967500 | METHOD AND KIT FOR THE CLASSIFICATION OF THYROID NODULES | HANEY, AMANDA MARIE | 12d |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16967500 | METHOD AND KIT FOR THE CLASSIFICATION OF THYROID NODULES | HANEY, AMANDA MARIE | 1682 | §101§112 | Non-Final OA | 12d | Pending | Aug 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundação Pio Xii has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Amanda Marie Haney has the most, with 1 of Fundação Pio Xii's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
